MI Barbato, J Nashed, D Bradford, Y Ren… - Clinical Cancer …, 2024 - AACR
Abstract On March 16, 2023, the FDA approved dabrafenib in combination with trametinib
(Tafinlar, Mekinist; Novartis Pharmaceuticals Corporation) for the treatment of pediatric …